Delivery Order SPE2DR25D3010-SPE2DR26F88FE
Award Date 12/11/25
Potential Completion Date 12/12/25
Potential Value $17K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $1,591.96 to AmerisourceBergen Drug Corp for HUMIRA Pen 40 mg/0.8 mL, a pharmaceutical product used primarily for treating rheumatoid arthritis and other autoimmune conditions. This competitively awarded, firm fixed-price contract was executed on December 9, 2025, with an ultimate completion date of December 10, 2025. The award represents a child delivery order issued against AmerisourceBergen Drug Corp's larger indefinite...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on November 18, 2025, for the supply of HUMIRA (CF) Pen 40 mg/0.4 mls, a biologic immunosuppressant medication used to treat rheumatoid arthritis and other inflammatory conditions. The order, valued at $2,387.94 with a firm fixed price structure, will be fulfilled from the contractor's Conshohocken, Pennsylvania facility and is scheduled for completion by November 19, 2025. This is a non-set-aside...
- The Defense Logistics Agency awarded a delivery order valued at $35,031.32 to AmerisourceBergen Drug Corp for HUMIRA Pen 40mg/4ml pharmaceutical supplies on November 3, 2025, with completion by November 4, 2025. This firm fixed-price delivery order, issued without a set-aside designation, will be performed at the contractor's corporate office in Conshohocken, Pennsylvania. The award represents a competitive procurement under the company's broader pharmaceutical supply contract vehicle with the...
- The Defense Logistics Agency awarded a delivery order valued at $4,102.20 to AmerisourceBergen Drug Corp for HUMIRA (Pen) 40 mg/0.4 mL, a pharmaceutical product used in the treatment of rheumatoid arthritis and other inflammatory conditions. This competitively awarded, non-set-aside delivery order was issued on November 13, 2025, with an ultimate completion date of November 14, 2025, and employs firm fixed price terms. The product will be delivered to AmerisourceBergen's facility in...
- The Defense Logistics Agency awarded a $17,115.36 delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of HUMIRA Pen 40 mg/0.8 mL injectable medication. This contract represents a firm fixed price delivery order with no set-aside designation, indicating competitive award. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of July 25, 2025. As a child order, this award leverages...
- The Defense Logistics Agency awarded a $7,163.82 delivery order to AmerisourceBergen Drug Corp on November 17, 2025, for the supply of HUMIRA (adalimumab) 40 mg/0.4 mL prefilled pens. This competitively awarded, non-set-aside contract is classified as a firm fixed-price delivery order with an ultimate completion date of November 18, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract...
- The Defense Logistics Agency awarded a $20,688.02 firm fixed-price delivery order to AmerisourceBergen Drug Corp for HUMIRA (CF) Pen 40 mg/0.4 mL on November 14, 2025, with an ultimate completion date of November 17, 2025. This non-competitive delivery order represents a specific pharmaceutical procurement drawn from AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion global pharmaceutical support vehicle running through December...
- The Defense Logistics Agency awarded a delivery order valued at $14,131.43 to AmerisourceBergen Drug Corp for HUMIRA (CF) Pen 40 mg/0.4 mls, an injectable rheumatoid arthritis medication. This firm fixed price, non-set-aside delivery order was awarded on November 4, 2025, with an ultimate completion date of November 5, 2025. The work will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under the company's existing Indefinite...
- The Defense Logistics Agency awarded a $1,837.26 delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of HUMIRA Pen 40 mg/0.8 mL, a pharmaceutical product used in the treatment of rheumatoid arthritis and other autoimmune conditions. This non-set-aside, competitively awarded contract represents a firm fixed-price delivery order with a completion date of July 31, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. As the prime awardee,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 8, 2025, for the supply of HUMIRA (CF) Pen 40 mg/0.4 mL, a prescribed injectable medication used to treat rheumatoid arthritis and other inflammatory conditions. This competitively awarded, non-set-aside delivery order carries a ceiling value of $7,470.37 under firm fixed price terms, with an ultimate completion date of December 9, 2025. The order will be fulfilled from AmerisourceBergen's facility...